Abstract:
Described herein are devices and methods for treating eye conditions. Described is an ocular implant (105) including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber (ac), at least one outflow port communicates with the suprachoroidal space (schs) to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.
Abstract:
Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants (105) are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications. The implant can be reversibly deformed to a first shape, such as a generally linear shape conducive to insertion. Upon insertion, the implant can deform to a second shape, such as a generally non-linear shape conducive to retention within the eye. The shape also improves fluid flow from the anterior chamber and prevents or reduces clogging.
Abstract:
A method is provided for making a mask (6200) configured to improve the depth of focus of an eye of a patient. A substrate (6000) is provided with a mask forming feature (6008). The mask forming feature comprises an annular surface (6020) that has a curved profile (6016) that corresponds to the curvature of a corneal layer of the eye. A release layer (6080) is formed on the annular surface. A mask layer (6100) of a biocompatible metal is formed above the release layer. The mask layer is separated from the substrate.
Abstract:
Disclosed are masks configured to be implanted in a cornea of a patient. In one embodiment, the body of the mask has a light transmitting portion, a light blocking portion disposed about the light transmitting portion, and an outer periphery surrounding the light blocking portion. The mask is adapted to reside between two intracorneal layers of a cornea. In a preferred embodiment, the mask is formed from a material comprising a highly fluorinated polymeric material and an opacification agent and is resistant to degradation upon exposure to ultraviolet light. In another embodiment, the mask is formed from a material which comprises a polyanionic compound. In some embodiments, the mask includes one or more wound healing modulator compounds to aid in proper healing following implantation.
Abstract:
A mask (4200) configured to be implanted in a cornea of a patient to increase the depth of focus of the patient includes an anterior surface, a posterior surface, and a plurality of holes(4220). The anterior surface is configured to reside adjacent a first corneal layer. The posterior surface is configured to reside adjacent a second corneal layer. The plurality of holes extends at least partially between the anterior surface and the posterior surface. The holes of the plurality of holes are configured to substantially eliminate visible diffraction patterns.
Abstract:
This invention is a pliable intrastromal corneal insert (10) designed to be inserted into an inter-lamellar channel made within the cornea of a mammalian eye. It is made of a physiologically compatible polymer and may be used to adjust corneal curvature and thereby correct vision abnormalities. The insert (10) or segment may also be used to deliver therapeutic or diagnostic agents to the corneal interior or to the interior of the eye. The insert (10) subtends at least a portion of a ring, or "arc", encircling the anterior cornea (33) outside of the cornea's field of view but within the cornea's frontal diameter. The invention also includes both a minimally invasive procedure for inserting one or more of the devices into the cornea (12) as well as the thus corrected eye.
Abstract:
Disclosed are devices and methods for treatment of eye disease such as glaucoma. An implant is placed in the eye wherein the implant provides a fluid pathway for the flow or drainage of aqueous humor from the anterior chamber to the supraciliary or the suprachoroidal space, or to any space in the eye where drainage to that location will lower the intraocular pressure. The implant may include an elongate compressible structure and may be implanted in the eye using a delivery system that folds and or compresses the implant to provide a smaller cross-sectional area to allow a more minimally-invasive procedure. The compressibility of the implant is provided by a porous structure that may be collapsed by compression and delivered through a tube-shaped introducer.
Abstract:
Disclosed are devices and methods for treatment of eye disease such as glaucoma. An implant is placed in the eye wherein the implant provides a fluid pathway for the flow or drainage of aqueous humor from the anterior chamber to the supraciliary or the suprachoroidal space, or to any space in the eye where drainage to that location will lower the intraocular pressure. The implant may include an elongate compressible structure and may be implanted in the eye using a delivery system that folds and or compresses the implant to provide a smaller cross-sectional area to allow a more minimally-invasive procedure. The compressibility of the implant is provided by a porous structure that may be collapsed by compression and delivered through a tube-shaped introducer.
Abstract:
Described herein is a hand-held gonioscopic imaging system that can be used to continuously display, capture and record images of the iridocorneal angle within the eye during implantation procedures. The system can be used, for example, during device implantation procedures for the treatment of glaucoma such that landmark identification continues during implantation. Intuitive real-time images viewed through the imaging systems described herein appear to the user to move in the same horizontal orientation as the instrument is actually being moved. The systems described herein also provide independent illumination sources for the camera and the surgical microscope that also have independent illumination controls.
Abstract:
An intracorneal implant has a geometry bounded by a ring-shaped section of a cone, approximating a section of a sphere. The intracorneal implant has at least one region of modified elasticity. Typically, the intracorneal implant will have two or more regions of modified elasticity circumferentially spaced around the implant. The regions of modified elasticity affect the cone angle of the implant within each region and hence the corrective power of each region on the cornea. The intracorneal ring implant can be used for correction of various refractive defects of the vision, in particular, astigmatism or astigmatism combined with myopia or hyperopia. The implant may be formed as a ring, split ring, gapped ring or one or more segments of a ring.